| 25 May 2026 |
1-Testosterone Cypionate (DHB) Raw |
4.0 |
5g |
6.1g |
+22.7% |
96.16% |
Lab D |
| 25 May 2026 |
CJC-1295 With DAC |
4.2 |
15mg |
16.5mg |
+10.3% |
99.17% |
Lab B |
| 25 May 2026 |
Winstrol Oil (Stanozolol) |
4.0 |
250mg/ml |
228.0mg/ml |
-8.8% |
97.68% |
Lab E |
| 24 May 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
6.4 |
2mg |
1.8mg |
-11.0% |
97.51% |
Lab F |
| 24 May 2026 |
Cardiogen |
6.9 |
20mg |
22.3mg |
+11.7% |
96.50% |
Lab C |
| 24 May 2026 |
BAM15 |
4.0 |
10mg |
12.1mg |
+20.8% |
98.84% |
Lab D |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
6.2 |
2mg |
2.2mg |
+10.0% |
95.02% |
Lab B |
| 24 May 2026 |
Methylene Blue |
5.3 |
100mg |
108.1mg |
+8.1% |
95.44% |
Lab G |
| 24 May 2026 |
Primobolan E |
4.0 |
250mg/ml |
277.7mg/ml |
+11.1% |
95.50% |
Lab E |
| 24 May 2026 |
Anavar (Oxandrolone) |
5.8 |
100mg |
92.8mg |
-7.2% |
96.68% |
Lab A |
| 24 May 2026 |
CJC-1295 With DAC |
5.9 |
2mg |
2.5mg |
+24.1% |
95.90% |
Lab B |
| 24 May 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
5.4 |
2mg |
2.4mg |
+19.8% |
95.68% |
Lab B |
| 24 May 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
4.0 |
15mg |
15.9mg |
+6.1% |
96.54% |
Lab G |
| 24 May 2026 |
Supertest 450 |
5.4 |
100mg/ml |
120.3mg/ml |
+20.3% |
99.94% |
Lab E |
| 23 May 2026 |
BPC157 10mg + TB500 10mg Blend |
4.0 |
30mg |
30.8mg |
+2.8% |
95.33% |
Lab D |
| 23 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
4.7 |
15mg |
17.2mg |
+14.8% |
95.45% |
Lab A |
| 23 May 2026 |
KPV Oral |
5.0 |
10mg |
11.9mg |
+19.3% |
95.08% |
Lab F |
| 23 May 2026 |
T3 (Liothyronine) |
4.9 |
10mg |
10.9mg |
+9.3% |
95.18% |
Lab G |
| 23 May 2026 |
Tren Hex |
7.0 |
100mg/ml |
119.2mg/ml |
+19.2% |
95.24% |
Lab E |
| 21 May 2026 |
CJC-1295 With DAC |
8.0 |
30mg |
33.7mg |
+12.4% |
96.69% |
Lab E |
| 21 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
4.5 |
5mg |
5.8mg |
+16.6% |
99.88% |
Lab A |
| 21 May 2026 |
Retatrutide 30mg Pen Kit |
4.4 |
10mg |
10.6mg |
+5.5% |
99.57% |
Lab D |
| 21 May 2026 |
Tren Hex |
6.2 |
200mg/ml |
222.4mg/ml |
+11.2% |
95.82% |
Lab C |
| 21 May 2026 |
KPV Oral |
5.4 |
50mg |
58.8mg |
+17.6% |
99.63% |
Lab C |
| 21 May 2026 |
KPV Oral |
6.8 |
20mg |
19.5mg |
-2.7% |
96.90% |
Lab G |
| 21 May 2026 |
Retatrutide 30mg Pen Kit |
5.6 |
2mg |
1.7mg |
-14.9% |
98.98% |
Lab F |
| 21 May 2026 |
Supertest 450 |
5.0 |
100mg/ml |
115.1mg/ml |
+15.1% |
96.17% |
Lab G |
| 21 May 2026 |
T3 (Liothyronine) |
4.1 |
20mg |
22.1mg |
+10.4% |
95.18% |
Lab C |
| 20 May 2026 |
EPO |
4.0 |
30mg |
27.6mg |
-8.0% |
96.05% |
Lab B |
| 20 May 2026 |
Retatrutide 30mg Pen Kit |
4.1 |
15mg |
18.1mg |
+20.6% |
99.82% |
Lab F |
| 19 May 2026 |
BPC157 5mg + TB500 5mg Blend |
4.0 |
20mg |
18.0mg |
-10.0% |
98.45% |
Lab G |
| 19 May 2026 |
Masteron E (Drostanolone E) |
4.0 |
100mg/ml |
119.3mg/ml |
+19.3% |
95.51% |
Lab C |
| 17 May 2026 |
FOXO4 |
6.4 |
50mg |
58.5mg |
+17.1% |
97.11% |
Lab A |
| 17 May 2026 |
GLOW GHK-CU 35mg+TB500 10mg+BPC157 5mg |
6.1 |
50mg |
58.7mg |
+17.5% |
99.77% |
Lab C |
| 17 May 2026 |
Tamoxifen (Nolvadex) Raw |
4.8 |
5g |
5.5g |
+9.9% |
97.83% |
Lab A |
| 29 Jan 2026 |
Masteron E (Drostanolone E) |
4.9 |
250mg/ml |
217.5mg/ml |
-13.0% |
99.26% |
Lab D |
| 29 Jan 2026 |
Masteron E (Drostanolone E) |
6.0 |
300mg/ml |
340.4mg/ml |
+13.5% |
98.62% |
Lab B |
| 29 Jan 2026 |
T3 (Liothyronine) |
4.0 |
10mg |
9.5mg |
-4.6% |
99.04% |
Lab B |
| 26 Jan 2026 |
5-amino-1MQ |
4.0 |
20mg |
22.6mg |
+12.8% |
97.35% |
Lab E |
| 26 Jan 2026 |
CJC-1295 With DAC |
4.0 |
10mg |
11.0mg |
+9.9% |
95.20% |
Lab A |
| 26 Jan 2026 |
Prednisone |
6.9 |
25mg |
24.5mg |
-2.0% |
96.53% |
Lab D |
| 19 Jan 2026 |
LGD-4033 (Ligandrol) |
5.0 |
20mg |
19.4mg |
-3.0% |
96.82% |
Lab G |
| 19 Jan 2026 |
Primobolan E |
4.0 |
100mg/ml |
99.0mg/ml |
-1.0% |
97.69% |
Lab C |
| 9 Jan 2026 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
4.0 |
2mg |
2.4mg |
+21.2% |
97.96% |
Lab B |
| 9 Jan 2026 |
TrenMix 200 |
6.3 |
200mg/ml |
199.6mg/ml |
-0.2% |
99.51% |
Lab B |
| 7 Jan 2026 |
Methylene Blue |
4.0 |
20mg |
20.0mg |
+0.0% |
96.78% |
Lab C |
| 7 Jan 2026 |
Tamoxifen (Nolvadex) Raw |
6.3 |
1g |
0.9g |
-11.7% |
98.62% |
Lab B |
| 7 Jan 2026 |
Test Suspension |
5.1 |
300mg/ml |
306.8mg/ml |
+2.3% |
96.69% |
Lab G |
| 7 Jan 2026 |
TrenMix 200 |
7.0 |
200mg/ml |
240.5mg/ml |
+20.2% |
99.82% |
Lab G |
| 6 Jan 2026 |
T3 (Liothyronine) |
4.8 |
100mg |
122.6mg |
+22.6% |
97.53% |
Lab D |
| 6 Jan 2026 |
Tamoxifen (Nolvadex) Raw |
4.0 |
5g |
6.1g |
+22.9% |
95.22% |
Lab F |
| 29 Dec 2025 |
Prednisone |
4.4 |
10mg |
9.4mg |
-5.9% |
98.79% |
Lab A |
| 29 Dec 2025 |
Prednisone |
6.9 |
25mg |
28.8mg |
+15.1% |
98.23% |
Lab B |
| 29 Dec 2025 |
Primobolan E |
4.0 |
200mg/ml |
244.8mg/ml |
+22.4% |
97.70% |
Lab B |
| 29 Dec 2025 |
Test Suspension |
6.1 |
200mg/ml |
236.6mg/ml |
+18.3% |
95.38% |
Lab C |
| 12 Dec 2025 |
DSIP |
5.5 |
5mg |
5.1mg |
+2.7% |
99.58% |
Lab E |
| 12 Dec 2025 |
KPV Oral |
5.8 |
10mg |
10.0mg |
+0.5% |
95.46% |
Lab E |
| 12 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
5.7 |
20mg |
21.8mg |
+9.2% |
95.47% |
Lab B |
| 12 Dec 2025 |
Selank 10mg + Semax 10mg Blend |
5.5 |
10mg |
9.6mg |
-4.0% |
95.92% |
Lab E |
| 12 Dec 2025 |
TrenMix 200 |
4.0 |
300mg/ml |
341.2mg/ml |
+13.7% |
99.40% |
Lab B |
| 5 Dec 2025 |
FOXO4 |
6.8 |
30mg |
25.8mg |
-14.0% |
95.59% |
Lab D |
| 5 Dec 2025 |
Supertest 450 |
5.3 |
300mg/ml |
361.9mg/ml |
+20.6% |
96.67% |
Lab D |
| 23 Nov 2025 |
Cagrilintide 5mg + Semaglutide 5mg Blend |
7.1 |
10mg |
8.5mg |
-14.9% |
95.45% |
Lab G |
| 23 Nov 2025 |
Masteron E (Drostanolone E) |
4.1 |
200mg/ml |
224.7mg/ml |
+12.3% |
95.69% |
Lab F |
| 23 Nov 2025 |
Prednisone |
4.0 |
10mg |
10.0mg |
-0.5% |
96.10% |
Lab B |
| 17 Nov 2025 |
1-Testosterone Cypionate (DHB) Raw |
6.7 |
500g |
580.1g |
+16.0% |
98.87% |
Lab F |
| 17 Nov 2025 |
DSIP |
4.9 |
30mg |
35.2mg |
+17.3% |
99.59% |
Lab D |
| 17 Nov 2025 |
MT-1 |
4.0 |
5mg |
5.4mg |
+7.6% |
98.79% |
Lab C |
| 14 Nov 2025 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
6.1 |
50mg |
53.9mg |
+7.8% |
98.95% |
Lab E |
| 5 Nov 2025 |
DSIP |
4.2 |
20mg |
24.8mg |
+24.2% |
99.68% |
Lab C |
| 5 Nov 2025 |
Tamoxifen (Nolvadex) Raw |
4.2 |
5g |
4.7g |
-5.9% |
95.78% |
Lab G |
| 5 Nov 2025 |
Test Suspension |
5.8 |
300mg/ml |
339.1mg/ml |
+13.0% |
98.96% |
Lab A |
| 4 Nov 2025 |
LGD-4033 (Ligandrol) |
6.0 |
100mg |
113.3mg |
+13.3% |
95.98% |
Lab A |
| 4 Nov 2025 |
LGD-4033 (Ligandrol) |
8.2 |
100mg |
124.0mg |
+24.0% |
96.14% |
Lab F |
| 4 Nov 2025 |
MT-1 |
4.9 |
30mg |
31.8mg |
+6.0% |
95.15% |
Lab B |
| 17 Oct 2025 |
(2-Chloroethyl)benzene CAS 622-24-2 |
5.4 |
500g |
565.4g |
+13.1% |
95.85% |
Lab D |
| 17 Oct 2025 |
Chonluten |
10.0 |
50mg |
54.8mg |
+9.6% |
99.08% |
Lab G |
| 17 Oct 2025 |
Retatrutide 30mg Pen Kit |
5.8 |
10mg |
12.1mg |
+21.0% |
99.26% |
Lab C |
| 9 Oct 2025 |
Cardiogen |
5.7 |
2mg |
2.1mg |
+6.3% |
95.79% |
Lab G |
| 9 Oct 2025 |
LGD-4033 (Ligandrol) |
5.9 |
50mg |
60.3mg |
+20.6% |
98.55% |
Lab G |
| 3 Oct 2025 |
EPO |
4.0 |
20mg |
19.8mg |
-0.8% |
99.32% |
Lab G |
| 3 Oct 2025 |
Methylene Blue |
6.3 |
10mg |
10.9mg |
+9.2% |
98.96% |
Lab A |
| 3 Oct 2025 |
TrenMix 200 |
6.3 |
250mg/ml |
255.8mg/ml |
+2.3% |
97.99% |
Lab B |
| 3 Oct 2025 |
Winstrol Oil (Stanozolol) |
4.0 |
200mg/ml |
174.5mg/ml |
-12.8% |
99.20% |
Lab F |
| 30 Apr 2025 |
Semaglutide |
5.4 |
10mg |
11.69mg |
+16.9% |
99.96% |
Lab A |
| 30 Apr 2025 |
Mazdutide |
5.0 |
6mg |
6.82mg |
+13.7% |
99.58% |
Lab A |
| 30 Apr 2025 |
Mazdutide |
4.7 |
6mg |
6.9mg |
+15.0% |
99.51% |
Lab A |
| 30 Apr 2025 |
Retatrutide |
6.4 |
10mg |
10.86mg |
+8.6% |
99.72% |
Lab A |
| 30 Apr 2025 |
Tirzepatide |
6.0 |
10mg |
11.24mg |
+12.4% |
99.97% |
Lab A |
| 30 Apr 2025 |
Tirzepatide |
5.6 |
10mg |
11.53mg |
+15.3% |
99.94% |
Lab A |
| 30 Apr 2025 |
Retatrutide |
7.2 |
10mg |
10.61mg |
+6.1% |
99.72% |
Lab A |